Loading provider…
Loading provider…
Hematology & Oncology Physician in Skokie, IL
NPI: 1043297971Primary Practice Location
ELMHURST MEMORIAL HOSPITAL
155 E Brush Hill Rd, Elmhurst, IL
Primary Employer
Northshore University Healthsystem Faculty Practice Associates
northshore.org
HQ Phone
Get MD Joseph's Phone Numberphone_androidMobile
Get MD Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
1995 - 2026

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University of Illinois College of Medicine - Chicago
medicine.uic.edu
Medical School
Until 1993
Loyola University Medical Center
Fellowship • Hematology and Medical Oncology
1996 - 1999
Residency • Internal Medicine
1993 - 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 215 | 529 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 166 | 204 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 50 | 119 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 43 | 43 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 32 | 86 |
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
Authors: Larissa Meyer, William Cliby, William Tew, Deborah Armstrong, Robert Coleman, Ritu Salani
Publication Date: 2016-09
SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.
Authors: Julie Gralow, Melanie Royce, Gabriel Hortobagyi, Lawrence Flaherty
Publication Date: 2011-07-20
Authors: Chen, B, Stiff, P, Sloan, G, Kash, J, Manjunath, R, Pathasarathy, M, Oldenburg, D, Foreman, K E, Nickoloff, B J
Journal: Clin Immunol
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Docetaxel, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, PROCEDURE: Biopsy, PROCEDURE: Bone Scan, BIOLOGICAL: Pertuzumab
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Laboratory Biomarker Analysis, DRUG: Cyclophosphamide, DRUG: Paclitaxel, DRUG: Doxorubicin Hydrochloride
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Fulvestrant, DRUG: Alpelisib